In observance of Rare Disease Day 2020, Biorasi, LLC held a company-wide event and fundraiser to raise awareness for Angelman Syndrome. The company contributed over $4,000 to the Foundation for Angelman Syndrome Therapeutics. Read more about the highlights of this event >>
Biorasi, LLC and its Board of Directors are proud to announce the appointment of Chris O’Brien to the position of Chief Executive Officer (CEO). O’Brien will assume day-to-day leadership of Company operations, working closely with the Biorasi leadership team to deliver cutting-edge solutions for clinical research project management.
Celebrated Industry Veteran to Lead Scientific, Medical, and Regulatory Affairs at Biorasi
Miami, FL, Jan 29, […]
Florida-Based CRO seeks to expand offerings, global footprint, and headcount after successful investment transaction.
Biorasi, a leading […]
Leading Florida-based Contract Research Organization Partners With University to Train Tomorrow’s Medical Research Professionals
Miami, FL, Aug. […]
Mobile phone apps and wearable devices have a lot of potential to improve clinical studies. However, […]
Biorasi is proud to announce that leading industry publication Global Health & Pharma, also known as […]
For this week’s Biorasi Spotlight, meet Jennifer Royzis, Lead, Talent Acquisition at Biorasi, LLC.
How did you get […]